Dr Chhavi Sharma

PhD (Tumor Biology)

chhavi@manipaldubai.com

Experience

Dr. Sharma has received her doctoral degree in Cancer Biology from All India Institute of Medical Sciences, New Delhi, India. She did her graduate course in Biochemistry from University of Delhi and post-graduation (gold medalist) from Jamia Hamdard, New Delhi, India. She has qualified CSIR-JRF-NET and was among the top 20% of qualified students. She has also qualified Graduate Aptitude Test in Engineering (GATE)-2001, with 98.37 percentile and was ranked thirty-one all over India. She is member of Indian Association of Cancer Research (IACR) and Society of Young Scientists (SYS) AIIMS, New Delhi, India. Dr. Chhavi’s current research interests includes molecular basis of chemoprevention and their therapeutic potential. Also, she has presented her research findings in several scientific conferences at national and international levels and published in reputed peer-reviewed scientific journals.

Areas of Interest in teaching

At Manipal University Dubai, she is currently teaching papers related to Tissue culture, Cell and Tissue Engineering, Regenerative Medicine, Bioethics, Forensic Science, and Human Anatomy and Physiology.

Top 5 research publications/ Projects

• Cancer Therapeutics
• Molecular basis of Cancer Chemoprevention

Selected Publications:
• Sharma C, Ahmed T, Sasidharan S, Ahmed M, Hussain A (2009). Use of Gemcitabine and Ginger Extract Infusion May Improve the Efficiency of Cervical Cancer Treatment. African Journal of Biotechnology, 8 (24): 7087-7093.

• Hussain A, Sasidharan S, Ahmed T, Ahmed M, Sharma C. Clove (Syzygium Aromaticum) Extract Potentiates Gemcitabine Cytotoxic Effect on Human Cervical Cancer Cell Line. International Journal of Cancer Research. 2009; 5 (3): 95-104.

• Kirubahar B, Chhavi Sharma, Utpal Das, Debayan Ghosh. The proteins behind fuzz Removal. Colourage. 2007 Dec; 122-124.

• Sharma C, Kaur J, Shishodia S, Aggarwal BB and Ralhan R. Curcumin down regulates Smokeless tobacco-induced NF-κB activation and its downstream targets COX-2 and Bcl-2 in human oral premalignant cell culture and cancer cell line. Toxicology. 2006 Nov; 228:1-15.

• Ralhan R, Chakravarti N, Kaur J, Sharma C, Kumar A, Mathur M, Bahadur S, Shukla NK, Deo SV. Clinical significance of altered expression of retinoid receptors in oral precancerous and cancerous lesions: relationship with cell cycle regulators. Int J Cancer. 2006 Mar 1; 118:1077-89.

• Arora S, Kaur J, Sharma C, Mathur M, Bahadur S, Shukla NK, Deo SV, Ralhan R. Stromelysin3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis. Clin Cancer Res. 2005 Mar 15; 11:2272-84.

Only one instance of a ScriptManager can be added to the page.